FDA reauthorization bill passes Senate committee

Share this article:
 
A funding reauthorization bill that regulates the Food and Drug Administration cleared a hurdle Wednesday when a Senate committee approved it.
 
The legislation, approved by the Health, Education, Labor and Pensions Committee, reauthorizes user fees that drug and medical device industries pay to the FDA. It also adds a new fee for companies that make generic medications, specifically allowing the government to collect $299 million each year in fees from the generic drug industry for four years.
 
If the bill passes, it also would allow FDA reviewers to speed up the clearance of products for rare disease. The language also calls for developing incentives for "development of new qualified infectious disease products (QIDPs) by providing an additional five years of market exclusivity." That could be good news for nursing homes, where infectious diseases can be deadly to vulnerable seniors.
 
Congress has to send the bill to the president by Oct. 1. To read the HELP committee's bill, click here.
Share this article:

More in News

Long-term care continues to lead in deal volume and value: PwC report

Long-term care continues to lead in deal volume ...

Long-term care bucked healthcare industry trends with strong merger and acquisition activity in the second quarter of 2014, according to newly released data from professional services firm PricewaterhouseCoopers.

Empowering nurse practitioners could reduce hospitalizations from SNFs, study finds

Granting more authority to nurse practitioners is associated with reduced hospitalization of skilled nursing facility residents, according to recently published findings.

Pioneer ACO drops out of program, despite reductions in skilled nursing utilization

A California healthcare system has become the latest dropout from the Pioneer Accountable Care Organization program, despite reducing skilled nursing facility utilization and improving its readmission rates. Sharp HealthCare announced its decision in a quarterly financial statement released Tuesday.